Anticoagulants Industry Research Report 2024

Anticoagulants Industry Research Report 2024


Summary

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

According to APO Research, The global Anticoagulants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Anticoagulants include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
The Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson.
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Anticoagulants segment by Type

Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Anticoagulants Segment by Application

VTE
ACS/MI
AF
Others
Anticoagulants Segment by Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Anticoagulants by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Platelet Aggregation Inhibitors (PAI)
2.2.3 Low-Molecular-Weight Heparin (LMWH)
2.2.4 Direct Thrombin Inhibitor (DTI)
2.2.5 Direct Factor Xa Inhibitors (DFXa)
2.2.6 Vitamin K antagonists (VKA)
2.2.7 Others
2.3 Anticoagulants by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 VTE
2.3.3 ACS/MI
2.3.4 AF
2.3.5 Others
2.4 Assumptions and Limitations
3 Anticoagulants Breakdown Data by Type
3.1 Global Anticoagulants Historic Market Size by Type (2019-2024)
3.2 Global Anticoagulants Forecasted Market Size by Type (2025-2030)
4 Anticoagulants Breakdown Data by Application
4.1 Global Anticoagulants Historic Market Size by Application (2019-2024)
4.2 Global Anticoagulants Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Anticoagulants Market Perspective (2019-2030)
5.2 Global Anticoagulants Growth Trends by Region
5.2.1 Global Anticoagulants Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Anticoagulants Historic Market Size by Region (2019-2024)
5.2.3 Anticoagulants Forecasted Market Size by Region (2025-2030)
5.3 Anticoagulants Market Dynamics
5.3.1 Anticoagulants Industry Trends
5.3.2 Anticoagulants Market Drivers
5.3.3 Anticoagulants Market Challenges
5.3.4 Anticoagulants Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Anticoagulants Players by Revenue
6.1.1 Global Top Anticoagulants Players by Revenue (2019-2024)
6.1.2 Global Anticoagulants Revenue Market Share by Players (2019-2024)
6.2 Global Anticoagulants Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Anticoagulants Head office and Area Served
6.4 Global Anticoagulants Players, Product Type & Application
6.5 Global Anticoagulants Players, Date of Enter into This Industry
6.6 Global Anticoagulants Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Anticoagulants Market Size (2019-2030)
7.2 North America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Anticoagulants Market Size by Country (2019-2024)
7.4 North America Anticoagulants Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Anticoagulants Market Size (2019-2030)
8.2 Europe Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Anticoagulants Market Size by Country (2019-2024)
8.4 Europe Anticoagulants Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Anticoagulants Market Size (2019-2030)
9.2 Asia-Pacific Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Anticoagulants Market Size by Country (2019-2024)
9.4 Asia-Pacific Anticoagulants Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 Latin America
10.1 Latin America Anticoagulants Market Size (2019-2030)
10.2 Latin America Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Anticoagulants Market Size by Country (2019-2024)
10.4 Latin America Anticoagulants Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Anticoagulants Market Size (2019-2030)
11.2 Middle East & Africa Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Anticoagulants Market Size by Country (2019-2024)
11.4 Middle East & Africa Anticoagulants Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 Players Profiled
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Revenue in Anticoagulants Business (2019-2024)
12.1.4 Sanofi Anticoagulants Product Portfolio
12.1.5 Sanofi Recent Developments
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Information
12.2.2 Bristol-Myers Squibb Business Overview
12.2.3 Bristol-Myers Squibb Revenue in Anticoagulants Business (2019-2024)
12.2.4 Bristol-Myers Squibb Anticoagulants Product Portfolio
12.2.5 Bristol-Myers Squibb Recent Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Revenue in Anticoagulants Business (2019-2024)
12.3.4 Bayer Anticoagulants Product Portfolio
12.3.5 Bayer Recent Developments
12.4 Johnson & Johnson.
12.4.1 Johnson & Johnson. Company Information
12.4.2 Johnson & Johnson. Business Overview
12.4.3 Johnson & Johnson. Revenue in Anticoagulants Business (2019-2024)
12.4.4 Johnson & Johnson. Anticoagulants Product Portfolio
12.4.5 Johnson & Johnson. Recent Developments
12.5 Genentech (Roche)
12.5.1 Genentech (Roche) Company Information
12.5.2 Genentech (Roche) Business Overview
12.5.3 Genentech (Roche) Revenue in Anticoagulants Business (2019-2024)
12.5.4 Genentech (Roche) Anticoagulants Product Portfolio
12.5.5 Genentech (Roche) Recent Developments
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Revenue in Anticoagulants Business (2019-2024)
12.6.4 Boehringer Ingelheim Anticoagulants Product Portfolio
12.6.5 Boehringer Ingelheim Recent Developments
12.7 Lilly
12.7.1 Lilly Company Information
12.7.2 Lilly Business Overview
12.7.3 Lilly Revenue in Anticoagulants Business (2019-2024)
12.7.4 Lilly Anticoagulants Product Portfolio
12.7.5 Lilly Recent Developments
12.8 Daiichi Sankyo
12.8.1 Daiichi Sankyo Company Information
12.8.2 Daiichi Sankyo Business Overview
12.8.3 Daiichi Sankyo Revenue in Anticoagulants Business (2019-2024)
12.8.4 Daiichi Sankyo Anticoagulants Product Portfolio
12.8.5 Daiichi Sankyo Recent Developments
12.9 Otsuka
12.9.1 Otsuka Company Information
12.9.2 Otsuka Business Overview
12.9.3 Otsuka Revenue in Anticoagulants Business (2019-2024)
12.9.4 Otsuka Anticoagulants Product Portfolio
12.9.5 Otsuka Recent Developments
12.10 AstraZeneca
12.10.1 AstraZeneca Company Information
12.10.2 AstraZeneca Business Overview
12.10.3 AstraZeneca Revenue in Anticoagulants Business (2019-2024)
12.10.4 AstraZeneca Anticoagulants Product Portfolio
12.10.5 AstraZeneca Recent Developments
12.11 Pfizer
12.11.1 Pfizer Company Information
12.11.2 Pfizer Business Overview
12.11.3 Pfizer Revenue in Anticoagulants Business (2019-2024)
12.11.4 Pfizer Anticoagulants Product Portfolio
12.11.5 Pfizer Recent Developments
12.12 Aspen
12.12.1 Aspen Company Information
12.12.2 Aspen Business Overview
12.12.3 Aspen Revenue in Anticoagulants Business (2019-2024)
12.12.4 Aspen Anticoagulants Product Portfolio
12.12.5 Aspen Recent Developments
12.13 The Medicines Company
12.13.1 The Medicines Company Company Information
12.13.2 The Medicines Company Business Overview
12.13.3 The Medicines Company Revenue in Anticoagulants Business (2019-2024)
12.13.4 The Medicines Company Anticoagulants Product Portfolio
12.13.5 The Medicines Company Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings